These medications originated to treat type 2 diabetes , and were later approved in the US for weight loss by the Food and Drug Administration (FDA) under Ozempic and Wegovy brand names
In this context, GLP-1R agonists show remarkable potential as an emerging therapeutic agent.GLP-1R agonists reduce body weight, lower blood pressure, and improve lipid levels, as well as exerting anti-inflammatory and antioxidant effects by directly acting on GLP-1R in the heart and blood vessels, thereby reducing the risk of atherosclerotic thrombotic events (Solini et al., 2023)
Topical serums Copper peptide serums are the most common format and the most likely to cause purging
Calvani M, Benatti P, Mancinelli A, D'Iddio S, Giordano V, Koverech A, Amato A, Brass EP: Carnitine replacement in end-stage renal disease and hemodialysis
This is a ratio of myoinositol: di-chiro-inositol of 100:1, compared with 0.2:1 in women with PCOS